CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

NUVAXOVID

RegulatoryapprovedNUVAXOVIDPositive
AI Analysis

Summary

NUVAXOVID, a COVID-19 vaccine, is approved for active immunization in individuals aged 12 years and older. The approval encompasses both senior populations (65+) and younger adults (12-64 years of age).

Outcome Details

NUVAXOVID approved for individuals 65 years and older, and 12-64 years of age

Importance:7/10
Sentiment:
0.50
COVID-19vaccineregulatory approvalimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 27, 2026 3:50 PM

Read Original